ATE382046T1 - Herstellung einer polymorphen form eines thiazolidindionderivates - Google Patents

Herstellung einer polymorphen form eines thiazolidindionderivates

Info

Publication number
ATE382046T1
ATE382046T1 AT02080320T AT02080320T ATE382046T1 AT E382046 T1 ATE382046 T1 AT E382046T1 AT 02080320 T AT02080320 T AT 02080320T AT 02080320 T AT02080320 T AT 02080320T AT E382046 T1 ATE382046 T1 AT E382046T1
Authority
AT
Austria
Prior art keywords
thiazolidindone
derivative
preparation
polymorphous form
polymorphous
Prior art date
Application number
AT02080320T
Other languages
English (en)
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE382046(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909472.4A external-priority patent/GB9909472D0/en
Priority claimed from GBGB9912197.2A external-priority patent/GB9912197D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE382046T1 publication Critical patent/ATE382046T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
AT02080320T 1999-04-23 2000-04-19 Herstellung einer polymorphen form eines thiazolidindionderivates ATE382046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909472.4A GB9909472D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912197.2A GB9912197D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ATE382046T1 true ATE382046T1 (de) 2008-01-15

Family

ID=26315460

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02080320T ATE382046T1 (de) 1999-04-23 2000-04-19 Herstellung einer polymorphen form eines thiazolidindionderivates
AT00920889T ATE247653T1 (de) 1999-04-23 2000-04-19 Thiazolidindionderivat und seine verwendung als antidiabetikum

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00920889T ATE247653T1 (de) 1999-04-23 2000-04-19 Thiazolidindionderivat und seine verwendung als antidiabetikum

Country Status (40)

Country Link
US (2) US6815457B1 (de)
EP (3) EP1284268B1 (de)
JP (1) JP2002543075A (de)
KR (1) KR100744359B1 (de)
CN (1) CN1208335C (de)
AP (1) AP1495A (de)
AR (2) AR023568A1 (de)
AT (2) ATE382046T1 (de)
AU (1) AU765498B2 (de)
BG (1) BG65427B1 (de)
BR (1) BR0009934A (de)
CA (1) CA2370258A1 (de)
CO (1) CO5170424A1 (de)
CY (1) CY1107238T1 (de)
CZ (1) CZ20013799A3 (de)
DE (2) DE60037602T2 (de)
DK (2) DK1173434T3 (de)
DZ (1) DZ3155A1 (de)
EA (1) EA004534B1 (de)
ES (2) ES2204557T3 (de)
HK (1) HK1045154B (de)
HR (1) HRP20010773B1 (de)
HU (1) HUP0200929A3 (de)
IL (1) IL146110A0 (de)
MA (1) MA26785A1 (de)
MX (1) MXPA01010820A (de)
MY (1) MY128007A (de)
NO (1) NO320589B1 (de)
NZ (1) NZ515163A (de)
OA (1) OA11871A (de)
PE (1) PE20010040A1 (de)
PL (1) PL351686A1 (de)
PT (2) PT1173434E (de)
RS (1) RS50114B (de)
SK (1) SK286423B6 (de)
TR (1) TR200103061T2 (de)
TW (1) TW591027B (de)
UA (1) UA67843C2 (de)
UY (1) UY26120A1 (de)
WO (1) WO2000064892A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
AR023561A1 (es) 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
HRP20010773B1 (en) 1999-04-23 2005-06-30 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
CA2426117A1 (en) * 2000-09-26 2002-04-04 Dr. Reddy's Laboratories Limited Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (de) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphe Formen von Rosiglitazon Maleat
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (de) * 2004-01-28 2006-10-11 Usv Limited Verfahren zur herstellung von 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]phenylmethyl]thiazolidin-2,4-dionmaleat
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (de) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung fester Dosierungsformen von Rosiglitazonmaleat

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US6288095B1 (en) 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US20010044458A1 (en) * 1994-02-10 2001-11-22 Smithkline Beechamp P.L.C. Use of insulin sensitisers for treating renal diseases
WO1995021608A1 (en) 1994-02-10 1995-08-17 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6153632A (en) * 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
WO1998057635A1 (en) 1997-06-18 1998-12-23 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
EP1671637A3 (de) 1997-06-18 2007-12-19 SmithKline Beecham P.L.C. Behandlung der Diabetes mit Thiazolidindione und Sulphonylurea
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
US20020028768A1 (en) * 1997-06-18 2002-03-07 Smithkline Beecham P.L.C. Treatment of diabetes with rosiglitazone and insulin
TR199903057T2 (xx) 1997-06-18 2000-04-21 Smithkline Beecham Plc Diabetin tiazolidinedion ve metformin ile tedavisi.
GB9712866D0 (en) 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
US20020045649A1 (en) * 1997-07-18 2002-04-18 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
CZ20013801A3 (cs) 1999-04-23 2002-07-17 Smithkline Beecham Plc Nový léčivý přípravek
AR023561A1 (es) 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
HRP20010773B1 (en) 1999-04-23 2005-06-30 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CA2426117A1 (en) 2000-09-26 2002-04-04 Dr. Reddy's Laboratories Limited Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation

Also Published As

Publication number Publication date
EP1173434A2 (de) 2002-01-23
SK286423B6 (sk) 2008-09-05
CN1355801A (zh) 2002-06-26
CA2370258A1 (en) 2000-11-02
EP1284268B1 (de) 2007-12-26
DK1284268T3 (da) 2008-04-28
DZ3155A1 (fr) 2000-11-02
HUP0200929A2 (en) 2002-08-28
EA004534B1 (ru) 2004-06-24
HK1055293A1 (en) 2004-01-02
AR023568A1 (es) 2002-09-04
MA26785A1 (fr) 2004-12-20
KR100744359B1 (ko) 2007-07-30
EP1903043A1 (de) 2008-03-26
DE60037602D1 (de) 2008-02-07
PL351686A1 (en) 2003-06-02
HK1045154A1 (en) 2002-11-15
CZ20013799A3 (cs) 2002-04-17
EP1284268A1 (de) 2003-02-19
UA67843C2 (uk) 2004-07-15
HUP0200929A3 (en) 2004-03-29
MY128007A (en) 2007-01-31
MXPA01010820A (es) 2002-06-04
DK1173434T3 (da) 2003-12-08
RS50114B (sr) 2009-03-25
CY1107238T1 (el) 2012-11-21
HRP20010773B1 (en) 2005-06-30
PT1173434E (pt) 2003-12-31
NO320589B1 (no) 2005-12-27
US6815457B1 (en) 2004-11-09
EA200101119A1 (ru) 2002-04-25
TW591027B (en) 2004-06-11
AU765498B2 (en) 2003-09-18
ES2204557T3 (es) 2004-05-01
ES2298327T3 (es) 2008-05-16
KR20020028873A (ko) 2002-04-17
AP1495A (en) 2005-11-30
UY26120A1 (es) 2000-12-29
BR0009934A (pt) 2002-06-04
EP1173434B1 (de) 2003-08-20
YU75201A (sh) 2004-09-03
PE20010040A1 (es) 2001-03-10
WO2000064892A3 (en) 2001-01-25
OA11871A (en) 2006-03-27
BG106119A (en) 2002-05-31
ATE247653T1 (de) 2003-09-15
JP2002543075A (ja) 2002-12-17
AU4130600A (en) 2000-11-10
NO20015149L (no) 2001-12-17
HRP20010773A2 (en) 2002-10-31
DE60037602T2 (de) 2009-01-08
WO2000064892A2 (en) 2000-11-02
DE60004658D1 (de) 2003-09-25
NZ515163A (en) 2004-02-27
TR200103061T2 (tr) 2002-05-21
US20040092555A1 (en) 2004-05-13
CO5170424A1 (es) 2002-06-27
HK1045154B (en) 2004-06-25
BG65427B1 (bg) 2008-07-31
CN1208335C (zh) 2005-06-29
PT1284268E (pt) 2008-03-10
AR023564A1 (es) 2002-09-04
IL146110A0 (en) 2002-07-25
SK14912001A3 (sk) 2002-02-05
DE60004658T2 (de) 2004-06-24
NO20015149D0 (no) 2001-10-22

Similar Documents

Publication Publication Date Title
DE60037602D1 (de) Herstellung einer polymorphen Form eines Thiazolidindionderivates
DE60037395D1 (de) Herstellung eines halbleiter-bauelementes
DE60045698D1 (de) Antireflexzusammensetzung einer Hartmaske
DE60043174D1 (de) Turbinenleitapparat
DE60000079D1 (de) Konfigurationsverfahren eines Telekommunikationssystems
MA26816A1 (fr) Derives d'amino-triazolopyridine
DE69734931D1 (de) Herstellung einer honigwabenstruktur
DE60008859D1 (de) Verbindungsstruktur einer teleskopstange
DE60035080D1 (de) Statoraufbau eines Hochgeschwindgkeitsmotors
DE69916232D1 (de) Zusammensetzung zur Herstellung einer Metall-Keramik-Beschichtung
DE69834007D1 (de) Endpol eines Drehmelders
DE60019960D1 (de) Herstellung von isobutencopolymere
DE60112431D1 (de) Verwendung von biguanidederivaten zur herstellung eines vernarbungsfördernden medikaments
DE60037443D1 (de) Herstellung eines kondensators durch bildung einer mit halbkugel-korn-silizium versehenen siliziumelektrode
DE60109545D1 (de) Verfahren zur Herstellung einer Aromazusammensetzung auf Pilzbasis
DE69731016D1 (de) Herstellung einer Trehalulose enthaltende Polysaccharidzusammensetzung.
DE60029130D1 (de) Gerät zur herstellung einer schutzatmosphäre
DE60018173D1 (de) Giessform zur herstellung eines kühlelementes
PT1218340E (pt) Derivados da 4-hidroxibifenil hidrazida
DE69732479D1 (de) Herstellung einer feuerfesten ausbesserungsmasse
DE60003470D1 (de) Verfahren zur Herstellung eines Triarylamindimeres
DE69920553D1 (de) Flansch eines hohlen Gegenstandes
DE60038610D1 (de) Neue kristalline formen eines macrolidantibiotikums
DE60128896D1 (de) Herstellung einer hochkopplungs-flash-zelle
EE05609B1 (et) Dibensotiasepiiniderivaatide valmistamismeetod

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1284268

Country of ref document: EP

REN Ceased due to non-payment of the annual fee